{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:14:55Z","timestamp":1649204095704},"reference-count":33,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1080\/10428190500126323","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T13:34:24Z","timestamp":1126100064000},"page":"1357-1363","source":"Crossref","is-referenced-by-count":3,"title":["Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?"],"prefix":"10.1080","volume":"46","author":[{"given":"Daniel","family":"Steinbach","sequence":"first","affiliation":[]},{"given":"Jana","family":"Friedrich","sequence":"additional","affiliation":[]},{"given":"Kristin","family":"Dawczynski","sequence":"additional","affiliation":[]},{"given":"Silke","family":"Furchtbar","sequence":"additional","affiliation":[]},{"given":"Bernd","family":"Gruhn","sequence":"additional","affiliation":[]},{"given":"Susann","family":"Wittig","sequence":"additional","affiliation":[]},{"given":"Felix","family":"Zintl","sequence":"additional","affiliation":[]},{"given":"Axel","family":"Sauerbrey","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200301000-00004"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.15.2001"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1200\/JCO.2001.19.10.2705","volume":"19","author":"Creutzig U","year":"2001","journal-title":"J Clin Oncol"},{"key":"CIT0004","first-page":"48","volume":"2","author":"Gottesman MM","year":"2002","journal-title":"Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200111000-00008"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290016773"},{"key":"CIT0007","first-page":"1086","volume":"94","author":"Leith CP","year":"1999","journal-title":"Blood"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.10.708"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109097659"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3212"},{"key":"CIT0011","first-page":"782","volume":"89","author":"Gerrard G","year":"2004","journal-title":"Haematologica"},{"key":"CIT0014","first-page":"85","volume":"44","author":"Plasschaert SL","year":"2003","journal-title":"High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children. Leuk Lymphoma"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01378.x"},{"key":"CIT0016","first-page":"2092","volume":"91","author":"den Boer ML","year":"1998","journal-title":"Relationship between major vault protein\/ lung resistance protein, multidrug resistance-associated pro-tein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402541"},{"key":"CIT0020","first-page":"1083","volume":"9","author":"Steinbach D","year":"2003","journal-title":"Chin Cancer Res"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood-2003-12-4126","volume":"103","author":"Plasschaert SL","year":"2004","journal-title":"Blood"},{"key":"CIT0023","first-page":"2181","volume":"102","author":"Benderra Z","year":"2003","journal-title":"Blood"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402305"},{"key":"CIT0025","first-page":"1067","volume":"93","author":"Rots MG","year":"1999","journal-title":"Differential methotrexate resistance in childhood T- versus common\/PreB-acute lymphoblastic leukemia can be measured by an in situ thymidylate syrithase inhibition assay, but not by the MTT Assay. Blood"},{"key":"CIT0026","first-page":"3310","volume":"95","author":"Schrappe M","year":"2000","journal-title":"German-Austrian-Swiss ALL-BFM Study Group. Blood"},{"key":"CIT0027","first-page":"3320","volume":"9","author":"Nakanishi T","year":"2003","journal-title":"Chin Cancer Res"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03122.x"},{"key":"CIT0029","first-page":"29","volume":"457","author":"Elgie AW","year":"1999","journal-title":"Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML. Adv Exp Med Biol"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401331"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00593.x"},{"key":"CIT0033","first-page":"4541","volume":"102","author":"Holleman A","year":"2003","journal-title":"Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000116607"},{"key":"CIT0035","first-page":"2959","volume":"89","author":"Hongo T","year":"1997","journal-title":"In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood"},{"key":"CIT0036","first-page":"2723","volume":"90","author":"Kaspers GJ","year":"1997","journal-title":"In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood"},{"key":"CIT0037","first-page":"259","volume":"92","author":"Kaspers GJ","year":"1998","journal-title":"Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.9.3352"},{"key":"CIT0039","first-page":"2879","volume":"96","author":"Zwaan CM","year":"2000","journal-title":"Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190500126323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T09:20:56Z","timestamp":1586424056000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190500126323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,8,3]]},"published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1080\/10428190500126323"],"URL":"https:\/\/doi.org\/10.1080\/10428190500126323","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}